MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

A new aroma in the new world

H. Fajardo, A. Medina, P. Gomez, r. Medina (tegucigalpa, Honduras)

Meeting: 2017 International Congress

Abstract Number: 109

Keywords: Non-motor Scales, Olfactory dysfunction, Parkinsonism

Session Information

Date: Monday, June 5, 2017

Session Title: Parkinson's Disease: Non-Motor Symptoms

Session Time: 1:45pm-3:15pm

Location: Exhibit Hall C

Objective: Investigate if olfactory impairment in PD patients  are related with other non motor symptoms

Background: Non motor symptoms (NMS) can precede Parkinson’s Disease (PD) motor phenomenology, like impaired olfaction. Recently olfactory assessment  has been included as one of the supportive tests of the Movement Disorders Society (MDS) clinical diagnostic criteria for PD; Despite the fact of its certainty in PD diagnosis an olfactory screening is not included in the MDS-UPDRS I non motor aspects of daily living due that olfaction can not be routinely evaluated by a questionnaire. Different methods for assessing olfaction have been developed. In Honduras, as well as other regions of Central America, olfactory testing has not been assessed neither nonmotor symptoms; the relationship between each NMS is inconclusive

Methods: Olfaction was evaluated in 30 consecutive unselected nondemented patients, fulfilling UKPDSBB criteria for PD using Sniffin Sticks Test (SST) in San Felipe Hospital Tegucigalpa, Honduras. Olfaction was classified as normosmics or impaired olfaction depending on age and sex cutoffs of SST. Non motor symptoms were evaluated using MDS-UPDRS-I. Relationships between olfactory groups and non motor symptoms was evaluated by Fishers exact test and Bivariate correlation between SST and UPDRS-III was performed.

Results: 53.3% were male. Mean age was 67±11 years, and mean MDS-UPDRS-III ON score was 30.1±15.13. The mean onset of disease was 61±13.3 years. The gap between symptoms onset and initiation of dopaminergic replacement therapy was 5.27±5.26 years and we found a mean LEDD of 2375±1541, in addition 36.6% had less than equal to primary schooling. Overall frequency of impaired olfaction in PD patients was 70%. No correlation was found between olfaction and schooling (p>0.1). The most frequent NMS screened was cognitive impairment, followed by fatigue.

Relationship was found between impaired olfaction and cognitive impairment (p <0.05) but not between other non motor symptoms. No correlation was found between olfactory impairment and UPDRS III score

Conclusions: Olfactory assessment shows to be reliable and is not affected by schooling, relationship between impaired olfaction and cognition was found. Ongoing of this study continues using specific scales for each non motor symptom.

References: Rossi, M., Perez-Lloret, S., Millar Vernetti, P., Drucaroff, L., Costanzo, E., Ballesteros, D., Bril, A., Cerquetti, D., Guinjoan, S. and Merello, M. (2015), Olfactory Dysfunction Evaluation Is Not Affected by Comorbid Depression in Parkinson’s Disease. Mov Disord., 30: 1275–1279. doi:10.1002/mds.26276

To cite this abstract in AMA style:

H. Fajardo, A. Medina, P. Gomez, r. Medina. A new aroma in the new world [abstract]. Mov Disord. 2017; 32 (suppl 2). https://www.mdsabstracts.org/abstract/a-new-aroma-in-the-new-world/. Accessed June 14, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/a-new-aroma-in-the-new-world/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley